The Rheumatologist

Connect with us:

Home
Conditions
Drug Updates
Professional Topics
Practice Management
Technology
Resources
About Us
Advertise
Search

Read the Latest News About COVID-19

Read the Latest News About COVID-19

Enemy at the Gates: The Emerging Threat of COVID-19

Don’t Forget the Host: COVID-19 Cytokine Storm

Rheumatology in the Age of COVID-19: HCQ Shortages Driven by Small, Nonrandomized Study

Latest News

Should Biologic Therapy in Dermatology Be Interrupted During the Pandemic?

NEW YORK (Reuters Health)—The ongoing novel coronavirus pandemic has raised concerns about whether biologic therapy could make psoriasis patients more susceptible to SARS-CoV-2, the virus… [Read More]

Sanofi Can Produce Millions of Doses of HCQ, Potential Coronavirus Drug

PARIS (Reuters)—Sanofi SA will be able to provide millions of doses of hydroxychloroquine (HCQ) for patients with the illness caused by the novel coronavirus if… [Read More]

CMS Releases Additional Updates to MIPS 2019 Submission

The Centers for Medicaid & Medicare Services (CMS) announced last week an extension of the 2019 Merit-Based Incentive Payment System (MIPS) reporting deadline to 8… [Read More]

Stimulus Relief Aid for Rheumatology Practices: Details & How to Apply Now

Rheumatology practices are being hit hard by the COVID-19 pandemic. The sustainability of practices is being threatened and patient access to care is being reduced…. [Read More]

The Personal Side of COVID-19: Q&A with Philip A. Waller, MD

The outbreak of the SARS-CoV-2 virus is disrupting rheumatology clinics and practices all over the world. In the U.S., many providers are turning to telemedicine… [Read More]

Activating Yourself in the Time of Coronavirus

A timely and personal appeal to all those who can to become or remain civically active in this critical time. [Read More]

View More Latest News »

20_03_THR_FINAL_COVER

Current Issue

Issue Articles »
Subscribe »

From the Current Issue: March 2020

ACR/EULAR Release New Classification Criteria for IgG4-Related Disease

JNT Visual / shutterstock.com

Immunoglobulin G4-related disease (IgG4-RD) can cause fibroinflammatory lesions in nearly any organ, and diagnosis is challenging. ACR/EULAR classification criteria for IgG4-RD have been developed and validated in a large cohort of patients. These criteria have performed well in tests and should contribute substantially to future clinical, epidemiologic and basic science investigations. [Read More]

The Plight of the Retail Pharmacist

She wanted me to call in an antibiotic. My sister, a lawyer, often tells me how the ethics of her profession govern even her extra-professional… [Read More]

Risankizumab Demonstrates Superiority to Secukinumab for Plaque Psoriasis

In a phase 3, comparator study in adults with plaque psoriasis, patients taking
risankizumab achieved greater skin clearance than those taking secukinumab… [Read More]

FDA Advisory Committees Reject Oxycodegol (NKTR-181) Application

FDA advisory committees rejected the new drug application for oxycodegol, an opioid analgesic, due to a lack of data regarding it’s potential for abuse… [Read More]

The ACR Introduces a New Reproductive Health Guideline

Reproductive health can be a concern for patients with rheumatic diseases, and practitioners in both rheumatology and obstetrics/gynecology often work closely together. The 2020 ACR… [Read More]

View More From Current Issue »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

Connect with us:

Copyright © 2006–2020 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

This site uses cookies: Find out more.